Table 4.
Variable | RA | p-value | |||
---|---|---|---|---|---|
No | Yes | ||||
n = 121833 | n = 30487 | ||||
n | % | n | % | ||
Gender a | 0.94 | ||||
Female | 93307 | 76.59 | 23343 | 76.57 | |
Male | 28526 | 23.41 | 7144 | 23.43 | |
Age at baseline, years a | 0.81 | ||||
<25 | 5997 | 4.92 | 1528 | 5.01 | |
25–50 | 43520 | 35.72 | 10880 | 35.69 | |
>50 | 72316 | 59.36 | 18079 | 59.30 | |
Mean (SD)b | 52.72 (15.67) | 52.78 (15.67) | 0.55 | ||
Comorbidities a | |||||
Hypertension | 39095 | 32.09 | 10107 | 33.15 | <0.01 |
Dyslipidemia | 26355 | 21.63 | 5755 | 18.88 | <0.01 |
COPD | 12375 | 10.16 | 4548 | 14.92 | <0.01 |
Diabetes mellitus | 18175 | 14.92 | 4415 | 14.48 | 0.05 |
Asthma | 8576 | 7.04 | 3270 | 10.73 | <0.01 |
Chronic kidney disease | 1804 | 1.48 | 624 | 2.05 | <0.01 |
Cerebrovascular disease | 12466 | 10.23 | 2900 | 9.51 | <0.01 |
Alcohol use disorder | 235 | 0.19 | 92 | 0.30 | <0.01 |
Liver cirrhosis | 16784 | 13.78 | 6150 | 20.17 | <0.01 |
Malignancies | 28547 | 23.43 | 8567 | 28.10 | <0.01 |
Coronary artery disease | 12600 | 10.34 | 3567 | 11.70 | <0.01 |
Follow-up period, years, median c | 6.51 | 6.02 | <0.01 |
aχ2 test; bt-test; cWilcoxon’s rank-sum test. RA: rheumatoid arthritis; SD: standard deviation; COPD: chronic obstructive pulmonary disease.